Sarmen Sarkissian, MD of UC Irvine Health discusses the highlights in kidney cancer research specifically a phase II study on the use of Atezolizumab and Bevacizumab for patients with locally advanced or metastatic renal cell carcinoma. This was recorded at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.
Use of Atezolizumab, Bevacizumab, and Sunitinib in Kidney Cancer
